DILATATTSION KARDIOMIYOPATIYA: KLINIK VA PATOFIZIOLOGIK TAHLIL

Abduraimova Chinora Mirzaqul qizi; Boymurodova Sevara Amirullo qizi; Abdullayeva Diyora Baxtiyorovna

Authors

Abduraimova Chinora Mirzaqul qizi Samarqand davlat tibbiyot universiteti, klinik ordinatori
Boymurodova Sevara Amirullo qizi Samarqand davlat tibbiyot universiteti, klinik ordinatori
Abdullayeva Diyora Baxtiyorovna Samarqand davlat tibbiyot universiteti, klinik ordinatori

Keywords:

Dilatattsion kardiomiyopatiya, miokard disfunksiyasi, chap qorincha kengayishi, ejeksiya fraksiyasi, gemodinamik o‘zgarishlar, kardiomiopatiya, klinik tahlil.

Abstract

Ushbu maqolada dilatattsion kardiomiyopatiya (DKMP)ning klinik va patofiziologik jihatlari tahlil qilinadi. Tadqiqot davomida bemorlarning yurak struktura-funksional o‘zgarishlari, yurak qisqaruvchanlik funksiyasi va simptomatikaning rivojlanish mexanizmlari o‘rganildi. Maqolada DKMP bilan og‘rigan bemorlarda miokard qalinlashuvi, chap qorincha kengayishi, ejeksiya fraksiyasining pasayishi va gemodinamik o‘zgarishlar batafsil ko‘rib chiqildi. Olingan natijalar dilatattsion kardiomiyopatiyaning rivojlanishidagi asosiy patogenetik mexanizmlarni aniqlash, bemorlarni erta tashxislash va individual davolash strategiyalarini ishlab chiqishda muhim ahamiyatga ega ekanligini ko‘rsatadi.

References

1. Braunwald E. Heart Disease: A Textbook of Cardiovascular Medicine. 11th ed. Philadelphia: Elsevier; 2019.

2. Libby P., Bonow R.O., Mann D.L., Zipes D.P. Braunwald’s Heart Disease: Review and Assessment. Elsevier; 2020.

3. McKenna W.J., Maron B.J., Thiene G. Classification, epidemiology, and clinical manifestations of cardiomyopathies. Circulation. 2017;136(4):e123–e135.

4. Elliot P., Andersson B., Arbustini E. et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2008;29:270–276.

5. Towbin J.A., McKenna W.J., Abrams D.J. et al. 2019 HRS expert consensus statement on evaluation of cardiomyopathy. Heart Rhythm. 2019;16(5):e198–e246.

6. Richardson P., McKenna W., Bristow M. et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation. 1996;93:841–842.

7. Pieske B., Tschope C., de Boer R.A. et al. How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm. Eur Heart J. 2019;40:3297–3317.